MNAT1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.44169137633799E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.57360002595431E-09 |
Normal-vs-Stage2 |
2.95070000000397E-06 |
Normal-vs-Stage3 |
1.62714286489063E-12 |
Normal-vs-Stage4 |
8.1373999982759E-08 |
Stage1-vs-Stage2 |
2.024800E-01 |
Stage1-vs-Stage3 |
3.788400E-04 |
Stage1-vs-Stage4 |
4.034200E-02 |
Stage2-vs-Stage3 |
2.031600E-01 |
Stage2-vs-Stage4 |
6.663200E-01 |
Stage3-vs-Stage4 |
4.538600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
3.66373598126302E-15 |
Normal-vs-AfricanAmerican |
6.16139999999321E-05 |
Normal-vs-Asian |
4.43140000000453E-05 |
Caucasian-vs-AfricanAmerican |
3.707800E-01 |
Caucasian-vs-Asian |
3.217600E-01 |
AfricanAmerican-vs-Asian |
1.377180E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-15 |
Normal-vs-Female |
9.180599946923E-09 |
Male-vs-Female |
1.603810E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.766300E-04 |
Normal-vs-Age(41-60Yrs) |
2.78489997729281E-09 |
Normal-vs-Age(61-80Yrs) |
1.99840144432528E-15 |
Normal-vs-Age(81-100Yrs) |
9.52490000000195E-05 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.986200E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.621000E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.521400E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.711980E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.274000E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.105400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.126000E-01 |
Normal-vs-Grade 2 |
2.63909999964618E-07 |
Normal-vs-Grade 3 |
<1E-12 |
Normal-vs-Grade 4 |
2.39229969167809E-10 |
Grade 1-vs-Grade 2 |
4.078100E-03 |
Grade 1-vs-Grade 3 |
1.034600E-04 |
Grade 1-vs-Grade 4 |
4.259200000023E-06 |
Grade 2-vs-Grade 3 |
7.73020000000013E-05 |
Grade 2-vs-Grade 4 |
1.791970E-04 |
Grade 3-vs-Grade 4 |
2.767000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.16850000009272E-07 |
Normal-vs-ccB subtype |
1.7089663018055E-12 |
ccA subtype-vs-ccB subtype |
4.015900E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.02059471984717E-11 |
Normal-vs-N1 |
1.62447832963153E-12 |
N0-vs-N1 |
1.61430000000795E-06 |
|
|